research use only

Cremophor EL UGT chemical

Name: Cremophor EL
Brand: Selleck Chemicals
SKU: S6828
Availability: InStock
Rating: 5 (3 reviews)

Cat.No.S6828

Cremophor EL, a polyethoxylated surfactant, is a formulation vehicle used for various poorly-water soluble drugs, including the anticancer agent paclitaxel (Taxol). This compound is used in severe anaphylactoid hypersensitivity reactions, hyperlipidaemia, abnormal lipoprotein patterns, aggregation of erythrocytes and peripheral neuropathy.

Chemical Structure

Jump to

Quality Control

Batch: Purity: 99%

Related Targets	Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism
Featured Inhibitors	Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933

Solubility

In vitro
Batch:

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
Mass value Mass unit	Concentration value Concentration unit	Volume value Volume unit	Molecular weight (g/mol)

Dilution Calculator Molecular Weight Calculator

In vivo batch selection In vivo Batch:
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	1.250mg/ml	Taking the 1 mL working solution as an example, add 50 μL of 25 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
Clear solution	5% DMSO 1 95% Corn oil Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	1.250mg/ml	Taking the 1 mL working solution as an example, add 50 μL of 25 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg

Average weight of animals: g

Dosing volume per animal: μL

Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO

% Tween 80

% ddH₂O

% DMSO

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight		Formula	Storage (From the date of receipt)	2 years -20°C(in the dark) liquid
CAS No.	61791-12-6	--	Storage (From the date of receipt)	2 years -20°C(in the dark) liquid
Synonyms	CrEL		SMILES	C(C(CCl)OC(=O)N)Cl

Read more about storage stability CAS number SMILES

Mechanism of Action

In vitro	Cremophor EL is a widely used excipient. In the first 10 h, this compound at 5 mg/mL increases the impedance, then decreases it, and after 20 h of treatment, epithelial cell death is detected. This chemical in concentrations corresponding to clinical doses causes endothelial and epithelial toxicity. Both epithelial viability and monolayer integrity are seriously impaired at 10 to 50 mg/mL concentrations of this compound at 24-h treatment. It also enhances cell detachment.
In vivo	Cremophor EL-BB4 formulation-mediated photodynamic therapy (PDT) disseminated cancer in CT26-Luc mouse colon carcinoma model of intraperitoneal (IP) and significantly prolonged survival in mice when used along with white light.
References	[1] https://pubmed.ncbi.nlm.nih.gov/23362123/ [3] https://pubmed.ncbi.nlm.nih.gov/11527683/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2014-02-04)

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT00989131	COMPLETED	Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer	Oasmia Pharmaceutical AB	2009-02	PHASE3
NCT01692834	COMPLETED	Healthy	NeuroVive Pharmaceutical AB	2009-06	PHASE1
NCT00077246	COMPLETED	Lung Cancer	Memorial Sloan Kettering Cancer Center	2003-09	PHASE1; PHASE2
NCT00249002	TERMINATED	Hemodialysis Graft Dysfunction	Celgene	2005-11-01	PHASE2
NCT00095914	COMPLETED	Unspecified Adult Solid Tumor, Protocol Specific	National Institutes of Health Clinical Center (CC)	2004-09	PHASE1
NCT00073723	COMPLETED	Non-Small Cell Lung Cancer	Celgene Corporation	2003-12	PHASE1; PHASE2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):